Austin Drug Developer Gets $1.7m NIH Grant
Lung Therapeutics, Inc., an Austin-based pharmaceutical startup, has $1.69 million more to pump in the development of a drug that could help people afflicted with pneumonia.
AUSTIN BUSINESS JOURNAL
Lung Therapeutics, Inc., an Austin-based pharmaceutical startup, has $1.69 million more to pump in the development of a drug that could help people afflicted with pneumonia.
AUSTIN BUSINESS JOURNAL